SNCE
- Science 37 Holdings, Inc.
()
Overview
Company Summary
Science 37 Holdings, Inc. (SNCE) is a company that operates in the field of clinical research. Their main focus is to revolutionize the way clinical trials are conducted by utilizing technology and decentralized approaches.
Traditionally, clinical trials for new drugs or medical interventions are conducted in specific locations, such as hospitals or research clinics. However, Science 37 has developed a platform that allows for virtual and decentralized clinical trials to be conducted remotely, leveraging the power of digital tools and telemedicine.
Through their platform, Science 37 connects patients, researchers, and healthcare providers, enabling the participation of a wider and more diverse population in clinical research. Patients can take part in trials from the comfort of their homes, reducing the need for travel and potentially improving recruitment and retention rates.
Science 37 provides the technology infrastructure and support required for remote trials, including telemedicine capabilities, secure data collection, and patient engagement tools. They work closely with pharmaceutical companies, contract research organizations (CROs), and other research institutions to design and execute these trials.
By reducing the barriers to entry and making clinical trials more accessible, Science 37 aims to accelerate the development of new treatments and therapies. Their approach has the potential to speed up the recruitment process, enhance patient engagement and retention, and collect real-world, patient-centered data, leading to more accurate and meaningful results.
In summary, Science 37 Holdings, Inc. is a company that pioneers the use of technology and decentralized approaches to conduct virtual clinical trials. Their platform connects patients, researchers, and healthcare providers, making clinical trials more accessible, convenient, and efficient.